Drug for Ocular Diseases - Investors Relations

Back Home About Fovea Drug Development Business Development Investors Relations News Contacts           Fovea is a private venture-backed company that raised over € 20.5 million ($ 25 million) in October 2005, through a Serie A equity financing round.  The international syndicate was led by Sofinnova Partners (France) and includes Abingworth Management (UK), The Wellcome Trust (UK), GIMV (Belgium) and Crédit Agricole Private Equity (France).